Phibro Animal Health (PAHC) EBITDA Margin: 2012-2025
Historic EBITDA Margin for Phibro Animal Health (PAHC) over the last 13 years, with Sep 2025 value amounting to 14.09%.
- Phibro Animal Health's EBITDA Margin rose 729.00% to 14.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.29%, marking a year-over-year increase of 344.00%. This contributed to the annual value of 8.52% for FY2025, which is 328.00% up from last year.
- Phibro Animal Health's EBITDA Margin amounted to 14.09% in Q3 2025, which was up 58.21% from 8.90% recorded in Q2 2025.
- In the past 5 years, Phibro Animal Health's EBITDA Margin ranged from a high of 14.09% in Q3 2025 and a low of -0.31% during Q3 2023.
- In the last 3 years, Phibro Animal Health's EBITDA Margin had a median value of 7.57% in 2024 and averaged 7.71%.
- As far as peak fluctuations go, Phibro Animal Health's EBITDA Margin crashed by 620bps in 2023, and later soared by 729bps in 2025.
- Phibro Animal Health's EBITDA Margin (Quarterly) stood at 9.58% in 2021, then plummeted by 310bps to 6.48% in 2022, then decreased by 19bps to 6.28% in 2023, then soared by 197bps to 8.26% in 2024, then spiked by 729bps to 14.09% in 2025.
- Its last three reported values are 14.09% in Q3 2025, 8.90% for Q2 2025, and 9.64% during Q1 2025.